SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-29
👔
Scribe Therapeutics, Inc.
@SCTX_InsiderForm 4 Filing: Avoro Ventures LLC Buys $36.3M of $SCTX
INSIDER PURCHASE
⚡ MATERIALITY: 8/10
corporate issuer
Scribe Therapeutics, Inc.
Ticker: $SCTX
Transaction Value
$36.3M
Price/Share: $15.16
transaction date
2026-07-24
Shares: 2,391,238
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Avoro Ventures LLC, holds the title of Director at Scribe Therapeutics, Inc..
On 2026-07-24, the insider transacted 2,391,238 shares.The shares were transacted at a weighted average price of $15.16 per share, resulting in a total market-relevant value of $36.3M.
Executive Summary Summary
Avoro Ventures LLC (Director) bought $36.3M of $SCTX
Post-Transaction Position: 3,030,983 shares
SEC Accession No: 0000902664-26-003270 (CIK: 1879253)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.